Form 8-K - Current report:
SEC Accession No. 0001829126-22-019677
Filing Date
2022-12-05
Accepted
2022-12-05 16:08:54
Documents
13
Period of Report
2022-11-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fussbrands_8-k.htm   iXBRL 8-K 23541
2 EXHIBIT 10.1 fussbrands_ex10-1.htm EX-10.1 28175
  Complete submission text file 0001829126-22-019677.txt   224901

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fbds-20221130.xsd EX-101.SCH 3230
4 XBRL LABEL FILE fbds-20221130_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE fbds-20221130_pre.xml EX-101.PRE 22361
7 EXTRACTED XBRL INSTANCE DOCUMENT fussbrands_8-k_htm.xml XML 3157
Mailing Address 80 BROAD STREET 5TH FLOOR NEW YORK NY 10004
Business Address 80 BROAD STREET 5TH FLOOR NEW YORK NY 10004 917-720-3366
Fuss Brands Corp. (Filer) CIK: 0000926844 (see all company filings)

EIN.: 841273503 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-34808 | Film No.: 221445023
SIC: 2834 Pharmaceutical Preparations